ID   EPHA1_HUMAN             Reviewed;         976 AA.
AC   P21709; A1L3V3; Q15405;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2004, sequence version 3.
DT   02-NOV-2010, entry version 131.
DE   RecName: Full=Ephrin type-A receptor 1;
DE            EC=2.7.10.1;
DE   AltName: Full=Tyrosine-protein kinase receptor EPH;
DE   Flags: Precursor;
GN   Name=EPHA1; Synonyms=EPH, EPHT, EPHT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=88070650; PubMed=2825356; DOI=10.1126/science.2825356;
RA   Hirai H., Maru Y., Hagiwara K., Nishida J., Takaku F.;
RT   "A novel putative tyrosine kinase receptor encoded by the eph gene.";
RL   Science 238:1717-1720(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=99299440; PubMed=10369740; DOI=10.1006/mcpr.1999.0228;
RA   Owshalimpur D., Kelley M.J.;
RT   "Genomic structure of the EPHA1 receptor tyrosine kinase gene.";
RL   Mol. Cell. Probes 13:169-173(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS VAL-160
RP   AND MET-900.
RX   MEDLINE=22737999; PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22616434; PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 286-976.
RC   TISSUE=Placenta;
RA   Tuzi N.L.;
RT   "An EGFR/eph chimeric receptor possesses ligand stimulated tyrosine
RT   kinase activity and promotes cell growth.";
RL   Submitted (MAY-1994) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-781, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=15951569; DOI=10.1074/mcp.M500089-MCP200;
RA   Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,
RA   Lauffenburger D.A., White F.M.;
RT   "Time-resolved mass spectrometry of tyrosine phosphorylation sites in
RT   the epidermal growth factor receptor signaling network reveals dynamic
RT   modules.";
RL   Mol. Cell. Proteomics 4:1240-1250(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-33 AND SER-34, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-781, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=17389395; DOI=10.1073/pnas.0608638104;
RA   Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
RT   "Multiple reaction monitoring for robust quantitative proteomic
RT   analysis of cellular signaling networks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-780; TYR-781; SER-906;
RP   SER-908; SER-910 AND SER-919, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-160; CYS-351; GLN-492; GLN-575;
RP   THR-585; LEU-697; LYS-703; ARG-807 AND MET-900.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor for members of the ephrin-A family. Binds with
CC       a low affinity to ephrin-A1.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Overexpressed in several carcinomas.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily.
CC   -!- SIMILARITY: Contains 2 fibronectin type-III domains.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SAM (sterile alpha motif) domain.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/EPHA1ID40461ch7q35.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M18391; AAA36747.1; ALT_SEQ; mRNA.
DR   EMBL; AF101171; AAD43440.1; -; Genomic_DNA.
DR   EMBL; AF101165; AAD43440.1; JOINED; Genomic_DNA.
DR   EMBL; AF101166; AAD43440.1; JOINED; Genomic_DNA.
DR   EMBL; AF101167; AAD43440.1; JOINED; Genomic_DNA.
DR   EMBL; AF101168; AAD43440.1; JOINED; Genomic_DNA.
DR   EMBL; AF101169; AAD43440.1; JOINED; Genomic_DNA.
DR   EMBL; AF101170; AAD43440.1; JOINED; Genomic_DNA.
DR   EMBL; AC092214; AAS07458.1; -; Genomic_DNA.
DR   EMBL; CH236959; EAL23789.1; -; Genomic_DNA.
DR   EMBL; CH471198; EAW51846.1; -; Genomic_DNA.
DR   EMBL; CH471198; EAW51847.1; -; Genomic_DNA.
DR   EMBL; BC130291; AAI30292.1; -; mRNA.
DR   EMBL; Z27409; CAA81796.1; -; mRNA.
DR   IPI; IPI00294250; -.
DR   PIR; A34076; A34076.
DR   RefSeq; NP_005223.4; -.
DR   UniGene; Hs.89839; -.
DR   PDB; 2K1K; NMR; -; A/B=536-573.
DR   PDB; 2K1L; NMR; -; A/B=536-573.
DR   PDB; 3HIL; X-ray; 2.00 A; A/B=911-974.
DR   PDB; 3KKA; X-ray; 2.40 A; A/B=911-974.
DR   PDBsum; 2K1K; -.
DR   PDBsum; 2K1L; -.
DR   PDBsum; 3HIL; -.
DR   PDBsum; 3KKA; -.
DR   ProteinModelPortal; P21709; -.
DR   SMR; P21709; 26-203, 292-536, 451-538, 616-896, 625-935.
DR   STRING; P21709; -.
DR   PhosphoSite; P21709; -.
DR   PRIDE; P21709; -.
DR   Ensembl; ENST00000275815; ENSP00000275815; ENSG00000146904.
DR   GeneID; 2041; -.
DR   KEGG; hsa:2041; -.
DR   CTD; 2041; -.
DR   GeneCards; GC07M143087; -.
DR   H-InvDB; HIX0033699; -.
DR   HGNC; HGNC:3385; EPHA1.
DR   HPA; CAB026144; -.
DR   MIM; 179610; gene.
DR   PharmGKB; PA27817; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG062180; -.
DR   InParanoid; P21709; -.
DR   BRENDA; 2.7.10.1; 247.
DR   Pathway_Interaction_DB; epha_fwdpathway; EPHA forward signaling.
DR   NextBio; 8291; -.
DR   ArrayExpress; P21709; -.
DR   Bgee; P21709; -.
DR   CleanEx; HS_EPHA1; -.
DR   Genevestigator; P21709; -.
DR   GermOnline; ENSG00000146904; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005003; F:ephrin receptor activity; IEA:InterPro.
DR   GO; GO:0005515; F:protein binding; IEA:InterPro.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kin...; IEA:InterPro.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd.
DR   InterPro; IPR008957; Fibronectin_III_dom.
DR   InterPro; IPR003961; FN_III.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR009030; Growth_fac_rcpt.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM_type.
DR   InterPro; IPR021129; SAM_type1.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR010993; Sterile_alpha_motif_homology.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR020770; Tyr_prot_kinase_Eph-A1/A2_rcpt.
DR   InterPro; IPR016257; Tyr_prot_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_prot_kinase_rcpt_V_CS.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 2.
DR   Gene3D; G3DSA:1.10.150.50; SAM_type; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   PANTHER; PTHR23256:SF280; Tyr_prot_kinase_Eph-A1/A2_rcpt; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00536; SAM_1; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49265; FN_III-like; 2.
DR   SUPFAM; SSF49785; Gal_bind_like; 1.
DR   SUPFAM; SSF57184; Grow_fac_recept; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF47769; SAM_homology; 1.
DR   PROSITE; PS01186; EGF_2; UNKNOWN_1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Glycoprotein; Kinase;
KW   Membrane; Nucleotide-binding; Phosphoprotein; Polymorphism; Receptor;
KW   Repeat; Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase.
FT   SIGNAL        1     23       Potential.
FT   CHAIN        24    976       Ephrin type-A receptor 1.
FT                                /FTId=PRO_0000016798.
FT   TOPO_DOM     24    547       Extracellular (Potential).
FT   TRANSMEM    548    568       Helical; (Potential).
FT   TOPO_DOM    569    976       Cytoplasmic (Potential).
FT   DOMAIN      332    437       Fibronectin type-III 1.
FT   DOMAIN      446    535       Fibronectin type-III 2.
FT   DOMAIN      624    884       Protein kinase.
FT   DOMAIN      913    976       SAM.
FT   NP_BIND     630    638       ATP (By similarity).
FT   MOTIF       974    976       PDZ-binding (Potential).
FT   COMPBIAS    191    329       Cys-rich.
FT   ACT_SITE    749    749       Proton acceptor (By similarity).
FT   BINDING     656    656       ATP (By similarity).
FT   MOD_RES      33     33       Phosphothreonine.
FT   MOD_RES      34     34       Phosphoserine.
FT   MOD_RES     599    599       Phosphotyrosine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     605    605       Phosphotyrosine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     780    780       Phosphothreonine.
FT   MOD_RES     781    781       Phosphotyrosine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     906    906       Phosphoserine.
FT   MOD_RES     908    908       Phosphoserine.
FT   MOD_RES     910    910       Phosphoserine.
FT   MOD_RES     919    919       Phosphoserine.
FT   MOD_RES     930    930       Phosphotyrosine; by autocatalysis
FT                                (Potential).
FT   CARBOHYD    338    338       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    414    414       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    478    478       N-linked (GlcNAc...) (Potential).
FT   VARIANT     160    160       A -> V (in dbSNP:rs4725617).
FT                                /FTId=VAR_028265.
FT   VARIANT     351    351       R -> C (in dbSNP:rs56006153).
FT                                /FTId=VAR_042115.
FT   VARIANT     492    492       R -> Q (in dbSNP:rs11768549).
FT                                /FTId=VAR_028266.
FT   VARIANT     575    575       R -> Q (in dbSNP:rs35719334).
FT                                /FTId=VAR_042116.
FT   VARIANT     585    585       A -> T (in dbSNP:rs34178823).
FT                                /FTId=VAR_042117.
FT   VARIANT     697    697       P -> L (in dbSNP:rs34372369).
FT                                /FTId=VAR_042118.
FT   VARIANT     703    703       E -> K (in a breast pleomorphic lobular
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_042119.
FT   VARIANT     807    807       S -> R (in dbSNP:rs56244405).
FT                                /FTId=VAR_042120.
FT   VARIANT     900    900       V -> M (in dbSNP:rs6967117).
FT                                /FTId=VAR_028267.
FT   CONFLICT    398    398       G -> A (in Ref. 2 and 4).
FT   CONFLICT    581    616       QRDRATDVDREDKLWLKPYVDLQAYEDPAQGALDFT -> H
FT                                VTAPPMWIERTSCAEALCGTSRHTRTLHREPWTLPGGWSNF
FT                                PS (in Ref. 1; AAA36747).
FT   HELIX       918    924
FT   HELIX       928    930
FT   HELIX       931    936
FT   HELIX       942    945
FT   HELIX       950    955
FT   HELIX       964    971
SQ   SEQUENCE   976 AA;  108067 MW;  9F8F2D6A8E683D95 CRC64;
     MERRWPLGLG LVLLLCAPLP PGARAKEVTL MDTSKAQGEL GWLLDPPKDG WSEQQQILNG
     TPLYMYQDCP MQGRRDTDHW LRSNWIYRGE EASRVHVELQ FTVRDCKSFP GGAGPLGCKE
     TFNLLYMESD QDVGIQLRRP LFQKVTTVAA DQSFTIRDLA SGSVKLNVER CSLGRLTRRG
     LYLAFHNPGA CVALVSVRVF YQRCPETLNG LAQFPDTLPG PAGLVEVAGT CLPHARASPR
     PSGAPRMHCS PDGEWLVPVG RCHCEPGYEE GGSGEACVAC PSGSYRMDMD TPHCLTCPQQ
     STAESEGATI CTCESGHYRA PGEGPQVACT GPPSAPRNLS FSASGTQLSL RWEPPADTGG
     RQDVRYSVRC SQCQGTAQDG GPCQPCGVGV HFSPGARGLT TPAVHVNGLE PYANYTFNVE
     AQNGVSGLGS SGHASTSVSI SMGHAESLSG LSLRLVKKEP RQLELTWAGS RPRSPGANLT
     YELHVLNQDE ERYQMVLEPR VLLTELQPDT TYIVRVRMLT PLGPGPFSPD HEFRTSPPVS
     RGLTGGEIVA VIFGLLLGAA LLLGILVFRS RRAQRQRQQR QRDRATDVDR EDKLWLKPYV
     DLQAYEDPAQ GALDFTRELD PAWLMVDTVI GEGEFGEVYR GTLRLPSQDC KTVAIKTLKD
     TSPGGQWWNF LREATIMGQF SHPHILHLEG VVTKRKPIMI ITEFMENGAL DAFLREREDQ
     LVPGQLVAML QGIASGMNYL SNHNYVHRDL AARNILVNQN LCCKVSDFGL TRLLDDFDGT
     YETQGGKIPI RWTAPEAIAH RIFTTASDVW SFGIVMWEVL SFGDKPYGEM SNQEVMKSIE
     DGYRLPPPVD CPAPLYELMK NCWAYDRARR PHFQKLQAHL EQLLANPHSL RTIANFDPRV
     TLRLPSLSGS DGIPYRTVSE WLESIRMKRY ILHFHSAGLD TMECVLELTA EDLTQMGITL
     PGHQKRILCS IQGFKD
//
